Jin Y - Search Results

1

Prognostic value of circulating C-reactive protein levels in patients with non-small cell lung cancer: a systematic review with meta-analysis.

Jin Y, Sun Y, Shi X, Zhao J, Shi L, Yu X. Jin Y, et al. J Cancer Res Ther. 2014 Nov;10 Suppl:C160-6. doi: 10.4103/0973-1482.145854. J Cancer Res Ther. 2014. PMID: 25450276 Free article.

2

Serum C-reactive protein as an important prognostic variable in patients with diffuse large B cell lymphoma.

Cao Y, Shi YX, Chen JO, Tan YT, Cai YC, Luo HY, Qiu MZ, Cai XY, Jin Y, Sun YL, Jiang WQ. Cao Y, et al. Among authors: jin y. Tumour Biol. 2012 Aug;33(4):1039-44. doi: 10.1007/s13277-012-0337-z. Epub 2012 Feb 11. Tumour Biol. 2012. PMID: 22328138

3

Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer.

Jin Y, Zhao L, Peng F. Jin Y, et al. Clinics (Sao Paulo). 2013 May;68(5):686-93. doi: 10.6061/clinics/2013(05)17. Clinics (Sao Paulo). 2013. PMID: 23778417 Free PMC article.

4

Meta-analysis to assess the efficacy and toxicity of docetaxel-based doublet compared with docetaxel alone for patients with advanced NSCLC who failed first-line treatment.

Jin Y, Sun Y, Shi X, Zhao J, Shi L, Hong W, Yu X. Jin Y, et al. Clin Ther. 2014 Dec 1;36(12):1980-1990. doi: 10.1016/j.clinthera.2014.08.015. Epub 2014 Sep 23. Clin Ther. 2014. PMID: 25256387

5

A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.

Wei XL, Wang FH, Zhang DS, Qiu MZ, Ren C, Jin Y, Zhou YX, Wang DS, He MM, Bai L, Wang F, Luo HY, Li YH, Xu RH. Wei XL, et al. Among authors: jin y. BMC Cancer. 2015 May 2;15:350. doi: 10.1186/s12885-015-1379-6. BMC Cancer. 2015. PMID: 25934640 Free PMC article.

6

Prognostic value of programed death ligand 1 in patients with solid tumors: A meta-analysis.

Jin Y, Zhao J, Shi X, Yu X. Jin Y, et al. J Cancer Res Ther. 2015 Aug;11 Suppl 1:C38-43. doi: 10.4103/0973-1482.163837. J Cancer Res Ther. 2015. PMID: 26323922 Free article.

7

Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer.

Jin Y, Chen M, Yu X. Jin Y, et al. Sci Rep. 2016 Aug 16;6:31636. doi: 10.1038/srep31636. Sci Rep. 2016. PMID: 27527915 Free PMC article.

8

Mutational profiling of non-small-cell lung cancer patients resistant to first-generation EGFR tyrosine kinase inhibitors using next generation sequencing.

Jin Y, Shao Y, Shi X, Lou G, Zhang Y, Wu X, Tong X, Yu X. Jin Y, et al. Oncotarget. 2016 Sep 20;7(38):61755-61763. doi: 10.18632/oncotarget.11237. Oncotarget. 2016. PMID: 27528220 Free PMC article.

9

Comparison of the 7(th) and proposed 8(th) editions of the AJCC/UICC TNM staging system for non-small cell lung cancer undergoing radical surgery.

Jin Y, Chen M, Yu X. Jin Y, et al. Sci Rep. 2016 Sep 19;6:33587. doi: 10.1038/srep33587. Sci Rep. 2016. PMID: 27641932 Free PMC article.

10

CYFRA 21-1 is an early predictor of chemotherapeutic effectiveness in advanced nonsmall cell lung cancer: An observational study.

Zhao T, Jin Y, Mao G, Wei Y, Wu G, Ye X, Zhou Y, Yuan G, Gao L, Hong Y, Chen Y, Hong C, Zhou H, Su D, Qin Z, Lu L. Zhao T, et al. Among authors: jin y. Medicine (Baltimore). 2016 Dec;95(52):e5748. doi: 10.1097/MD.0000000000005748. Medicine (Baltimore). 2016. PMID: 28033287 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,530 results

Search Page

Filters